FGK Clinical Research Signs Five-Year Agreement with OmniComm Systems for Multiple eClinical Products

    NEXT STORY
    Mateon Therapeutics Team Publishes Three New Peer-Reviewed Oncology Articles Outlining the Clinical Impact Potential of Its First-In-Class Anti-TGF-Beta RNA Therapeutic OT101/Trabedersen
    PREV STORY
    Fortress Biotech to Participate in December 2019 Investor Conferences
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Immune Therapeutics, Inc. Received Minutes From FDA Meeting for Lodonal™ for the Treatment for Crohn’s Disease

    ORLANDO, Fla., March 26, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Immune Therapeutics, ...

    author_avatar
    NASDAQ Market News

    Flexion Therapeutics Presents Updated Results from Clinical Trial Evaluating Repeat Administration of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) at Osteoarthritis Research Society International World Congress

    author_avatar
    NASDAQ Market News

    Clinical Trial Management System Market to Garner US$1.8 bn by 2019 – Persistence Market Research

    Global Clinical Trial Management System Market Boosted by Increased Clinical Research OutsourcingNew York, June ...

    author_avatar
    NASDAQ Market News